HK1028033A1
(en )
2001-03-02
Sulfonamides for treatment of endothelin-mediated disorders.
DK0941103T3
(en )
2002-04-15
Pharmaceutical preparation for the treatment of diabetes
NO976063D0
(en )
1997-12-23
Procedure for the treatment of diabetes
PT966436E
(en )
2003-03-31
ARILSULFONAMIDES AND ANALOGS AND THEIR APPLICATION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
HUP0103856A3
(en )
2003-11-28
Pharmaceutical composition for the treatment of acute disorders
ZA961150B
(en )
1997-02-12
Substituted isoxazoles for the treatment of inflammation.
PT977748E
(en )
2003-07-31
SUBSTITUTED BENZOPIRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION
NO995251D0
(en )
1999-10-27
Procedure for administering halotherapy
PT752870E
(en )
2002-09-30
USING MYCOBACTERIUM FOR THE TREATMENT OF TUMORS
BR9706908A
(en )
1999-07-20
Compositions for the treatment of renal failure comprising l-carnosine
DK1041985T3
(en )
2006-06-19
Combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of prophylactic disorders
PT983275E
(en )
2003-01-31
NEW DERIVATIVES OF TRIPTOLIDO ADVANTAGES FOR THE TREATMENT OF AUTOMATIC DISEASES
BR9806083A
(en )
1999-08-24
Pharmaceutical composition for the treatment of hapattite c
PT853959E
(en )
2003-03-31
COMPOSITION FOR THE TREATMENT OF ASBESTOS
PT928183E
(en )
2002-05-31
USES OF 1-HYDROXYL-2-PYRIDONENE FOR THE TREATMENT OF SEBORROIC DERMATITIS
PT1051172E
(en )
2005-03-31
METHOD FOR TREATMENT OF THE DPCO
IS5481A
(en )
2000-05-09
Combination therapy for the treatment of AIDS
PT970080E
(en )
2003-07-31
IMINO-AZA-ANTHRACYCLINONE DERIVATIVES FOR THE AMYLOIDS TREATMENT
BR1100506A
(en )
2004-06-08
Composition for the treatment of a human suffering from an intestinal disorder.
TR199601018A1
(en )
1997-07-21
Pharmaceutical compounds.
BR9507732A
(en )
1997-08-19
Pharmaceutical composition for the treatment of glaucoma
NL1000591C2
(en )
1996-12-20
Tissue.
ZA967281B
(en )
1998-03-02
Polymorphs of the pro drug 6-N-(L-ALA-L-ALA)-trovafloxacin.
ZA986324B
(en )
1999-02-02
Composition for the treatment of immunodeficiency disease
ZA9811598B
(en )
2000-10-11
A substance or composition for the treatment of cancer.